logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Elizabeth A. Eisenhauer

queen's university
H指数:73
被引数:6.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer

报告辅助全身治疗随机临床试验中的健康相关生活质量：常识肿瘤学和欧洲癌症研究与治疗组织的建议

Lancet Oncology
IF35.9
2026-09-290
PRE
Ian F Tannock; Michael Brundage; Christopher M Booth; Nathan I Cherny; Corneel Coens; Elizabeth A Eisenhauer; Jan Geissler; Johannes M Giesinger; Bishal Gyawali; Sjoukje F Oosting; Gregory R Pond; Jaap C Reijneveld; Enrique Soto-Perez-de-Celis; Michelle Tregear; Winette T A van der Graaf; Brooke E Wilson; Madeline L Pe
Common sense oncology values to action: a patient-led framework for randomized clinical trial design

常识性肿瘤学价值观转化为行动：由患者主导的随机临床试验设计框架

JNCI: Journal of the National Cancer Institute
IF0
2026-03-300
OAAI
Michelle L Tregear, PhD; Haydeé C Verduzco-Aguirre, MD, MHPE; Brian Shkabari, BHSc; Rachel Koven, MSc; Henry Scowcroft, MBioch, MSc; Viji Venkatash, BA; Michael D Brundage, MD, MSc; Runcie C W Chidebe, MSc; Elizabeth A Eisenhauer, MD; Bishal Gyawali, MD, PhD; Bhawna Sirohi, MBBS; Christopher M Booth, MD; Christopher G C A Jackson, MB ChB, MInstD, FRACP; null
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

在晚期癌症临床试验中报告与健康相关的生活质量数据时，应答者标准的重要性：常识肿瘤学与欧洲癌症研究与治疗组织的建议

lancet oncology
IF0
2025-09-010
PRE
Ian F Tannock; Madeline Lee Pe; Christopher M Booth; Michael Brundage; Nathan I Cherny; Corneel Coens; Elizabeth A Eisenhauer; Jan Geissler; Johannes M Giesinger; Bishal Gyawali; Sjoukje F Oosting; Gregory R Pond; Jaap C Reijneveld; Enrique Soto-Perez-de-Celis; Michelle Tregear; Winette T A van der Graaf
Guidance for discussants of randomized cancer trials at major meetings

重大会议中随机化癌症试验讨论员的指导原则

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-05-010
PRE
Eisenhauer, Elizabeth A.; Abdihamid, Omar; Booth, Christopher M.; Cherny, Nathan; Fojo, Antonio T.; Gyawali, Bishal; Marini, Bernard L.; Mohyuddin, Ghulam Rehman; Pe, Madeline; Pond, Gregory R.; Soto-Perez-de-Celis, Enrique; Tannock, Ian F.; Trapani, Dario; Tregear, Michelle; van der Graaf, Winette T. A.; Wilson, Brooke E.
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

定义真实数据在癌症临床研究中的作用: 欧洲癌症研究与治疗组织的立场

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-06-0136
OA
Saesen, Robbe; Van Hemelrijck, Mieke; Bogaerts, Jan; Booth, Christopher M.; Cornelissen, Jan J.; Dekker, Andre; Eisenhauer, Elizabeth A.; Freitas, Andre; Gronchi, Alessandro; Hernan, Miguel A.; Hulstaert, Frank; Ost, Piet; Szturz, Petr; Verkooijen, Helena M.; Weller, Michael; Wilson, Roger; Lacombe, Denis; van der Graaf, Winette T.
OV21/PETROC: A Randomized Gynecologic Cancer Intergroup Phase II Study of Intraperitoneal Versus Intravenous Chemotherapy Following Neoadjuvant Chemotherapy and Optimal Debulking Surgery in Epithelial Ovarian Cancer
OBSTETRICAL & GYNECOLOGICAL SURVEY
IF3.6
2018-04-010
OAAI
Provencher, D. M.; Gallagher, C. J.; Parulekar, W. R.; Ledermann, J. A.; Armstrong, D. K.; Brundage, M.; Gourley, C.; Romero, I.; Gonzalez-Martin, A.; Feeney, M.; Bessette, P.; Hall, M.; Weberpals, J. I.; Hall, G.; Lau, S. K.; Gauthier, P.; Fung-Kee-Fung, M.; Eisenhauer, E. A.; Winch, C.; Tu, D.; MacKay, H. J.
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

OV21/PETROC: 一项新辅助化疗和最佳切除手术治疗上皮性卵巢癌后腹膜内与静脉内化疗的随机妇科癌症II期研究

ANNALS OF ONCOLOGY
IF65.4
2018-02-0152
OAAI
Provencher, D. M.; Gallagher, C. J.; Parulekar, W. R.; Ledermann, J. A.; Armstrong, D. K.; Brundage, M.; Gourley, C.; Romero, I.; Gonzalez-Martin, A.; Feeney, M.; Bessette, P.; Hall, M.; Weberpals, J. I.; Hall, G.; Lau, S. K.; Gauthier, P.; Fung-Kee-Fung, M.; Eisenhauer, E. A.; Winch, C.; Tu, D.; MacKay, H. J.
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer

拉帕替尼联合foretinib，c-met，AXL和血管内皮生长因子受体抑制剂治疗人类表皮生长因子受体2 (HER-2) 阳性转移性乳腺癌的I期研究

BREAST CANCER RESEARCH
IF5.6
2017-05-0228
OAAI
Chia, Stephen K.; Ellard, Susan L.; Mates, Mihaela; Welch, Stephen; Mihalcioiu, Catalin; Miller, Wilson H., Jr.; Gelmon, Karen; Lohrisch, Caroline; Kumar, Vikaash; Taylor, Sara; Hagerman, Linda; Goodwin, Rachel; Wang, Tao; Sakashita, Shingo; Tsao, Ming S.; Eisenhauer, Elizabeth; Bradbury, Penelope

研究方向

暂未获取到该数据
N
Nancy Wainman
H 指数:18论文数:51被引数:1,130
C
Christopher M. Booth
H 指数:55论文数:590被引数:1.3万
M
Michael Brundage
H 指数:66论文数:424被引数:1.7万
L
Lesley Seymour
H 指数:76论文数:378被引数:3.5万
H
Hal W. Hirte
H 指数:57论文数:229被引数:1.8万
M
Ming‐Sound Tsao
H 指数:151论文数:1,571被引数:11.3万
R
Rachel Goodwin
H 指数:26论文数:167被引数:2,929
D
Denis Lacombe
H 指数:43论文数:167被引数:6.6万
K
Karl Bélanger
H 指数:22论文数:80被引数:3.3万
D
Dongsheng Tu
H 指数:81论文数:566被引数:3.8万